Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{183532,
        author = {MR. PAGAR ANIKET KAILAS and MR.RAUT KRUSHNA ANIL and MS SALVE SONAL SANJAY and MR.WADHAVE AMOL},
        title = {Pharmacogenomics: How to select right drug to right patient},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {3},
        pages = {2199-2204},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=183532},
        abstract = {Pharmacogenomics plays a crucial role in understanding how different people respond to medications, which helps improve treatment and drug development. It focuses on how our genes and complex genetic systems influence the way our bodies react to drugs. Recent advances in clinical research have led to the discovery of new biomarkers that can predict which patients are more or less likely to benefit from specific medications. The ultimate goal is to personalize treatment by giving the right drug, at the right dose, at the right time. This field considers not just genetics, but also environmental and personal factors that affect how drugs work in different individuals. Pharmacogenomics has the potential to revolutionize drug development, improve treatment effectiveness, and identify disease risks. This review aims to provide a foundation for developing new tools, strategies, and applications in pharmacogenomics.},
        keywords = {Pharmacogenomics, Genetic testing, Personalised medicine},
        month = {August},
        }